Clinical Trial Update: Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine [Phase 3]

View source ↗

Summary

Phase 3 study of a combined meningococcal A/C polysaccharide and Haemophilus influenzae type b conjugate vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis

Drugs mentioned

• A Group A, C Polysaccharide Meningococcal and Type b Haemophilus influenzae Conjugate Vaccine (Group A and C meningococcal polysaccharide-conjugate vaccine with Haemophilus influenzae type b polysaccharide conjugate)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Meningitis, Influenza | Phase 3 | Status: COMPLETED